Clearance Summary
George King Coumadin Plasma received FDA 510(k) clearance under submission number K161316, sponsored by George King Bio-Medical, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Hematology review panel. The statutory decision date of record is 2017-02-23.
- Submission: K161316
- Applicant / Sponsor: George King Bio-Medical, Inc.
- Clearance pathway: Traditional
- Review panel: Hematology
- Device class: Class II
- Regulation citation: 21 CFR 864.5425
- Decision date: 2017-02-23
Classification & Regulation
This clearance is catalogued under FDA product code GGN and 21 CFR 864.5425, within the Hematology review panel as a Class II device.